Astrotech (NASDAQ:ASTC) Stock Rating Upgraded by Wall Street Zen

Astrotech (NASDAQ:ASTC) was upgraded by Wall Street Zen from a “strong sell” rating to a “sell” rating in a research note issued to investors on Sunday.

Separately, Weiss Ratings raised Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, May 27th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Astrotech Stock Performance

Shares of ASTC traded down $0.22 during trading hours on Friday, reaching $9.26. 80,134 shares of the company traded hands, compared to its average volume of 356,747. The stock’s fifty day moving average is $13.71 and its 200 day moving average is $6.89. Astrotech has a 1-year low of $1.91 and a 1-year high of $68.85. The stock has a market cap of $16.67 million, a P/E ratio of -1.10 and a beta of 4.77.

Astrotech (NASDAQ:ASTC) last released its earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) earnings per share for the quarter. The firm had revenue of $0.34 million for the quarter. Astrotech had a negative return on equity of 81.85% and a negative net margin of 1,397.82%.

Institutional Trading of Astrotech

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Susquehanna International Group LLP bought a new position in Astrotech during the third quarter worth about $66,000. DRW Securities LLC boosted its holdings in Astrotech by 168.5% during the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after purchasing an additional 19,747 shares in the last quarter. Finally, J. Safra Sarasin Holding AG bought a new stake in shares of Astrotech in the 1st quarter valued at approximately $140,000. Institutional investors own 24.35% of the company’s stock.

About Astrotech

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.